Trust CO Of Vermont Biomarin Pharmaceutical Inc Transaction History

Trust CO Of Vermont

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 24, 2022	BUY	$82.16 - $96.94 $5,833 - $6,882	71 Added 244.83%	100 $8,000
Q2 2022 Jul 20, 2022	BUY	$71.48 - $86.85 $2,072 - $2,518	29 New	29 $2,000
Q1 2021 Apr 16, 2021	SELL	$74.73 - $90.69 $7,473 - $9,069	-100 Closed	0 $0
Q4 2019 Feb 06, 2020	SELL	$64.27 - $86.37 $9,640 - $12,955	-150 Reduced 60.0%	100 $8,000
Q3 2019 Oct 24, 2019	SELL	$67.4 - $85.11 $16,850 - $21,277	-250 Reduced 50.0%	250 $17,000
Q1 2019 May 01, 2019	BUY	$84.2 - $98.62 $42,100 - $49,310	500 New	500 $44,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Trust CO Of Vermont, based on Form 13F filings with the SEC.

Stay updated on Trust CO Of Vermont with notifications on news.